Skip to main content
ALBT
NASDAQ Technology

Shareholders to Vote on Massive Dilution and Reverse Stock Split to Fund Operations and Maintain Nasdaq Listing

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.78
Mkt Cap
$3.358M
52W Low
$0.513
52W High
$11.66
Market data snapshot near publication time

Summary

Avalon GloboCare Corp. has scheduled a special meeting for shareholders to vote on multiple proposals, including the conversion of various debt and preferred stock instruments into common shares, a significant equity grant, and a potential reverse stock split, all of which will lead to substantial dilution.


Key Events

  • Shareholder Meeting Scheduled

    A special meeting is set for March 30, 2026, for stockholders to vote on seven key proposals.

  • Massive Dilution from Debt & Preferred Conversions

    Shareholders will vote on approving the conversion of July 2025 Convertible Notes ($260,000 total value at $1.00/share conversion), December 2025 Note ($375,000 principal with highly dilutive 50% VWAP conversion terms plus 100,000 commitment shares), and Series C Convertible Preferred Stock ($3.8 million total value at $2.41/share conversion). These conversions could collectively result in a substantial increase in common shares.

  • Chairman's Preferred Stock Exchange

    Approval is sought for an exchange where Chairman Wenzhao Lu will receive 2,074,689 common shares for 5,000 shares of Series D Convertible Preferred Stock, representing a significant portion of current outstanding shares.

  • Equity Grant for Advisory Services

    Shareholders will vote on issuing 450,000 restricted common shares to a consultant for advisory services, further contributing to dilution.


Analysis

Avalon GloboCare Corp. is seeking shareholder approval for a series of highly dilutive proposals that collectively represent a substantial increase in the company's outstanding common stock. These proposals include the conversion of significant convertible notes and preferred stock, as well as a large equity grant for advisory services. The proposed transactions, particularly the conversion of Series C Preferred Stock and the December 2025 Note with unfavorable conversion terms, indicate a critical need for capital and will result in substantial dilution for existing common shareholders. Furthermore, the company is proactively seeking authorization for a reverse stock split, signaling anticipated future challenges in maintaining its Nasdaq listing, likely exacerbated by the proposed dilution. This combination of events points to significant financial strain and a material transfer of value away from current common equity holders.

At the time of this filing, ALBT was trading at $0.78 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.51 to $11.66. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALBT - Latest Insights

ALBT
May 11, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
8
ALBT
May 11, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
9
ALBT
Apr 21, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
9
ALBT
Apr 21, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
ALBT
Apr 20, 2026, 5:10 PM EDT
Filing Type: 424B3
Importance Score:
9
ALBT
Apr 17, 2026, 5:23 PM EDT
Filing Type: DEFA14A
Importance Score:
9
ALBT
Apr 17, 2026, 5:23 PM EDT
Filing Type: DEF 14A
Importance Score:
10
ALBT
Apr 17, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
ALBT
Apr 08, 2026, 5:19 PM EDT
Filing Type: S-1
Importance Score:
9
ALBT
Apr 02, 2026, 4:27 PM EDT
Filing Type: PRE 14A
Importance Score:
9